期刊文献+

缬沙坦合联合比索洛尔治疗心力衰竭并室性早搏的临床观察 被引量:7

Effect of valsartan combined with bisoprolol in the treatment of heart failure with premature ventricular beats
下载PDF
导出
摘要 目的观察和探讨缬沙坦合并比索洛尔治疗心衰合并室性早搏的临床疗效。方法选取我院2010年5月~2011年5月期间收治的心衰合并室性早搏患者共计96例,将其随机分成治疗组48例及对照组48例,其中,治疗组患者给予缬沙坦、比索洛尔联合治疗;对照组患者仅给予单纯缬沙坦治疗。结果经治疗后,治疗组中显效23例,有效21例,总有效率达91.7%;对照组中显效20例,有效18例,总有效率为79.2%。治疗组总有效率明显高于对照组。所有患者的LVEF、LVESD、LVEDD均得到不同程度提高,同时治疗组效果明显优于对照组。且上述差异明显(P<0.05),具有统计学意义。结论采用缬沙坦合并比索洛尔治疗心衰合并室性早搏可有效提高患者心功能,临床应用治疗效果显著,值得我们广泛应用。 Objective To observe the clinical curative effect of valsartan combined with bisoprolol in the treatment of heart failure with premature ventricular beats.Methods From May 2010 to May 2011 in our hospital,96 patients were divided into the treatment group(48 cases) and the control group(48 cases),the treatment group were given valsartan combined with bisoprolol;patients in the control group were only given simple valsartan.Results the total effective rate of the treatment group was 91.7%;the control group was 79.2%.The total effective rate of the treatment group was significantly higher than that of the control group.LVEF,LVESD,LVEDD of all patients were improved the treatment group was obviously better than the control group.And the differences are significant(P0.05).Conclusion The effect of valsartan combined with bisoprolol in the treatment of heart failure with premature ventricular contractions can effectively improve the cardiac function,is worth to widely use.
作者 李沂
出处 《四川医学》 CAS 2013年第5期594-595,共2页 Sichuan Medical Journal
关键词 缬沙坦 比索洛尔 心力衰竭 室性早搏 valsartan bisoprolol heart failure premature ventricular contractions
  • 引文网络
  • 相关文献

参考文献6

  • 1阚毅.依那普利联合缬沙坦治疗慢性心力衰竭的临床观察[J].实用全科医学,2008,6(4):375-376. 被引量:13
  • 2周霞,丁黎,贺建昌,徐贵丽,郭晓烽,陈国伟.富马酸比索洛尔片在健康人体内的生物等效性评价[J].中国新药杂志,2007,16(20):1712-1715. 被引量:5
  • 3冯燕娴,汤凤英,石增刚,桑更生.血清载脂蛋白B与冠脉病变程度的相关性研究[J].中华全科医学,2011,9(9):1340-1342. 被引量:5
  • 4Celebier M,Kaynak MS,Ahindz S. Validated HPLC method develop- ment : the simultaneous analysis of amlodipine and valsartan in samples for liver perfusionstudies [ J ]. Hacettepe University Journal of the Fac- ulty of Pharmacy, 2008, 28 ( 1 ) : 15 - 30.
  • 5Li H,Wang Y,Jiang Y. A liquid chromatography/tandem mass spec- trometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma [ J]. J chromatogr BAnalyt Tech- nol Biomed Life Sci, 2007,852(1-2) :436 -442.
  • 6Krzesinski JM,Scheen AJ. A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist( amlodipine besylate) and an angiotensinreceptor blocker ( valsartan ) : Exforge [J]. Rey Med l,iege, 2007,62( 11 ) :688 -694.

二级参考文献18

共引文献20

同被引文献55

  • 1无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3698
  • 2Jabbour A, Macdonald PS, Keogh AM, et al. Differences between beta-blockers in patients with chmnic heart failures and chronic obstructive pulmonary disease: a randomized crossover trial [ J ]. J Am Cardiol,2010,55(17) :1750 - 1757.
  • 3Rutlen FH,Zuithoff NP,Hak E,et al.Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease[J].Arch Intern Med,2010,170(10):880.
  • 4Felder RB,Yu Y,Zhang ZH,et al.Phrmacological treatment for heart failure:a view from the brain[J].Clin Pharmacol,2009,86(2):216.
  • 5Grassi G,Seravalle G,Quarti-Trevano F,et al.Sympathetic activation in congestive heart failure:evidence,consequences and therapeutic implications[J].Current Vascular Pharmacology,2009,7(2):137.
  • 6Jabbour A,Macdonald PS,Keogh AM,et al.Differences between beta-blockers in patients with chmnic heart failures and chronic obstructive pulmonary disease:a randomized crossover trial[J].J Am Cardiol,2010,55(17):1780.
  • 7Coletta AP,Clark AL,Cleland JG.Clinical trials update from the Heart Failure Society of America and the American Heart Association meetings in 2008:SADHARTCHF,COMPARE,MOMENTUM,thyroid hormone analogue study,HF-ACTION,IPRESERVE,beta-interferon study,BACH and ATHENA[J].Eur J Heart Fail,2009,11(2):214.
  • 8Karaye KM.Relationship between Tei index and left ventrieular geometric patterns in ahypertensive population:a cross-sectional study[J].Cardiovasc Uhrasound,2011,9(1):21.
  • 9Kiczak L,Paslawska U,Bania J,et al.Increased expression of interleukin-1beta and its novel Splice variant in canine hearts with volume over load[J].Cytokine,2008,44(3):352.
  • 10Vesely D L.Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure,renal failure and cancer[J].Clin Exp Pharmacol Physiol,2009,33(3):169.

二级引证文献89

;
使用帮助 返回顶部